CompoAtlas

AromaFix

Natural health product licensed in Canada

Licence holder
Naturaceutik
NPN or DIN-HM
80145651
Status
Active licence
Licence date
26 November 2025
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Extrait d'isoflavones de trèfle rouge

Source : Trifolium pratense - sommité (herbe)

Potency : 40 mg ÉAI Isoflavones

100 mgNot calculated
Bore

Source : Citrate de bore

126 microgrammesNot calculated

Non-medicinal ingredients

Stéarate de magnésium, Hypromellose

PopulationAgeQuantity per servingFrequency
Population not specifiedminimum: 18 years2 Capsule1 Tous les jours
Femmes périmenopausalminimum: 18 years2 Capsule1 Tous les jours

Uses authorised in Canada

Aide à réduire/atténuer/diminuer la perte (de la densité minérale) osseuse (DMO) chez les femmes en postménopause, lorsque combiné à un apport suffisant de calcium et de vitamine D. Pourrait réduire les symptômes graves et fréquents liés à la ménopause (tels que les bouffées de chaleur et/ou les sueurs nocturnes).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80145651

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line